Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
life sciences
national blog main
national top stories
new york blog main
2
×
new york top stories
pfizer
2
×
san diego blog main
san diego top stories
abiraterone
ac immune
acorda therapeutics
aduro biotech
agenus
akcea therapeutics
aldeyra therapeutics
aleksandra rizo
alexion pharmaceuticals
alzheimer's disease
anylam pharmaceuticals
apalutamide
atypical hemolytic uremic syndrome
bill cassidy
biogen
biotech
boulder/denver blog main
boulder/denver top stories
caelum biosciences
cancer
cancer immunotherapy
cardiomyopathy
celgene
chuck grassley
clinical trials
corvus pharmaceuticals
crenezumab
deals
dengue fever
department of health and human services
What
drug
2
×
year
2
×
ago
akcea
alnylam
alzheimer’s
amyloidosis
approved
attr
available
battle
bio
companies
debilitating
different
disease
fail
fda
gene
genetic
increases
latest
medicines
oks
patients
pfizer
pharmaceutical
plan
prescription
price
prices
raise
rare
roundup
sets
start
therapies
transthyretin
typically
Language
Current search:
drug
×
year
×
pfizer
×
" new york blog main "
×
@xconomy.com
5 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More